Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionGlenmede Trust Co Na
Latest Disclosed Ownership81,701 shares
Latest Disclosed Value $ 11,587,652
Glenmede Trust Co Na reports 47.23% decrease in ownership of NBIX / Neurocrine Biosciences, Inc.

On February 17, 2026 - Glenmede Trust Co Na filed a 13F-HR form disclosing ownership of 81,701 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $11,587,652 USD as of December 31, 2025. The entity filed a previous 13F-HR on May 15, 2025 disclosing 154,827 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -47.23% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 81,701 -73,126 -47.23 11,588 -32.33 0.0250
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 154,827 -8,529 -5.22 17,124 -23.21 0.0919
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 163,356 153,095 1,492.01 22,298 1,786.46 0.1138
2024-11-13 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,261 -828 -7.47 1,182 -22.54 0.0057
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,089 -1,862 -14.38 1,527 -14.56 0.0077
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,951 -202 -1.54 1,786 3.06 0.0090
2024-02-13 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,153 10,127 334.67 1,733 409.71 0.0090
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,026 -6,238 -67.34 340 -63.71 0.0019
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,264 0 0.00 938 0.00 0.0053
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,264 -7,559 -44.93 938 -53.36 0.0053
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,823 6,525 63.36 2,009 83.81 0.0118
2022-11-16 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,298 -4,765 -31.63 1,093 -25.54 0.0069
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,063 -1,750 -10.41 1,468 -6.85 0.0086
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,813 -4,800 -22.21 1,576 -14.35 0.0077
2022-02-15 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 21,613 -10,269 -32.21 1,840 -39.81 0.0087
2021-11-15 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 31,882 -3,451 -9.77 3,057 -11.08 0.0158
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 35,333 -529 -1.48 3,438 -1.41 0.0178
2021-05-18 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 35,862 -4,734 -11.66 3,487 -10.38 0.0188
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 40,596 17,363 74.73 3,891 74.17 0.0214
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 23,233 -3,000 -11.44 2,234 -30.19 0.0134
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 26,233 6,971 36.19 3,200 54.59 0.0196
2020-05-20 2020-03-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 19,262 0 0.00 2,070 0.00 0.0094
2020-02-12 2019-12-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 19,262 1,066 5.86 2,070 26.30 0.0094
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 18,196 8,884 95.40 1,639 108.52 0.0075
2019-08-13 2019-06-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 9,312 -10 -0.11 786 -4.26 0.0034
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 9,322 -10 -0.11 821 23.27 0.0037
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 9,332 112 1.21 666 -41.22 0.0032
2018-11-15 2018-09-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 9,220 -8 -0.09 1,133 24.92 0.0045
2018-11-05 2018-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COMMON 64125C109 9,228 -1,280 -12.18 907 11.29 0.0040
2018-08-15 2018-06-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 9,228 -1,280 907
2018-05-15 2018-03-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 10,508 0 0.00 815 0.00 0.0034
2018-02-15 2017-12-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 10,508 0 0.00 815 26.75 0.0034
2017-11-14 2017-09-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 10,508 9,908 1,651.33 643 2,472.00 0.0028
2017-08-14 2017-06-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 600 0 0.00 25 0.00 0.0001
2017-05-16 2017-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COMMON 64125C109 600 600 25 0.0001
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 0 -41 -100.00 0 -100.00
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 41 0 0.00 1 0.00 0.0000
2016-08-05 2016-06-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 41 0 0.00 1 0.00 0.0000
2016-04-28 2016-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COMMON 64125C109 41 -79 -65.83 1 -83.33 0.0000
2016-04-26 2016-03-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 41 1
2016-02-11 2015-12-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 120 -29,280 -99.59 6 -97.46 0.0000
2015-02-06 2011-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COMMON 64125C109 29,400 29,400 236 0.0334
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.